The complex interplay between right ventricular dysfunction and atrial fibrillation – a narrative review-Reference-Cited by-同舟云学术

The complex interplay between right ventricular dysfunction and atrial fibrillation – a narrative review

Published:2023-05-08 Issue:2 Volume:61 Page:77-83
ISSN:2501-062X
Container-title:Romanian Journal of Internal Medicine
language:en
Short-container-title:

Author:

Vijan Ancuta¹²,Daha Ioana Cristina¹²,Delcea Caterina¹²,Dan Gheorghe-Andrei¹²³

Affiliation:

1. 1 Carol Davila University of Medicine and Pharmacy , Bucharest

2. 2 Colentina Clinical Hospital , Bucharest , Romania

3. 3 Joint senior author

Abstract

Abstract Atrial fibrillation (AF) is one of the most common sustained arrhythmias in clinical practice, associated with multiple comorbidities and complication. The potential predictors of AF onset and perpetuation or specific drivers of complications need future investigation. Right ventricular (RV) dysfunction plays an important role in the development of new-onset AF warranting in-depth analysis in relation to AF. RV may play a significant role in a better characterization of the cardiac substrate of AF patients. The relation between RV dysfunction and AF is bidirectional as AF may be one of the causes of RV dysfunction and their coexistence worsens the overall patient prognosis. Our aim is to present in a narrative review the most relevant data regarding the complex relationship between AF and RV dysfunction.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/rjim-2023-0004

Reference54 articles.

1. HINDRICKS, G., POTPARA, T., DAGRES, N., BAX, J.J., BORIANI, G., DAN, G.A., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2021;42(5):373–498.

2. MOU, L., NORBY, F.L., CHEN, L.Y., O’NEAL, W.T., LEWIS, T.T., LOEHR, L.R., et al. Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities). Circ. Arrhythmia Electrophysiol. 2018;11(7):1–10.

3. LIPPI, G., SANCHIS-GOMAR, F., CERVELLIN, G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int. J. Stroke 2021;16(2):217–221.

4. SCHNABEL, R.B., YIN, X., GONA, P., LARSON, M.G., BEISER, A.S., MCMANUS, D.D., et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet 2015;386(9989):154–162.

5. VÎJAN, A.E., DAHA, I.C., DELCEA, C., DAN, G.A. Determinants of prolonged length of hospital stay of patients with atrial fibrillation. J. Clin. Med. 2021;10(16).